Clinical Trial

Emotions From Salivary Biomarkers in an Architectural Context

Study acronym: Archi'Motion
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 14, 2026 (before its estimated June 14, 2026 completion). Its status may not reflect the trial's current state.
Summary
Architecture influences our well-being. People's behavior and mood changes in different spaces are directly related to the architectural qualities of the built environment. Neuroarchitecture is a discipline that combines neuroscience and architecture to design spaces adapted to the psychological and physiological needs of users. Several studies related to neuroarchitecture have been conducted according to different architectural parameters such as style, natural environment, lighting, color, and sunlight pattern. Recent studies show that emotional states can be evaluated by physiological responses. This physiological regulation comes from the action of enzymes and hormones that represent the activity of the autonomic nervous system. Measuring specific biomarkers through non-invasive biological tests in saliva provides physiological data on an individual's emotional state in response to stimuli, particularly visual or tactile.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-03-26; most recent amendment 2026-04-09.
Trial Details
NCT Number NCT07507266
Lead Sponsor Sys2Diag
Collaborators: Centre National de la Recherche Scientifique, France
Conditions Emotions
Enrollment 60 participants
Start Date 2026-06-09
Primary Completion 2026-06-14 (estimated)
Study Completion 2028-06-14 (estimated)
Updated on ClinicalTrials.gov 2026-04-14